SkyePharma Plc is poised to pay off years of fixed-income debt following commitments from institutional investors to buy shares in the company. This is expected to raise gross proceeds of £112 million, sufficient to pay off debt while leaving a residual £8.4 million for future investment. The company announced the capital-raising measures on 31 March, together with the release of its 2013 financial results.
